Melanoma of choroid is an infrequent but insidious malignancy. Typically, the tumor spread goes to the liver first, bringing a poor prognosis to almost all patients with this type of cancer.
Ipilimumab, an anti-CTLA antibody, has potential of eliciting autoimmune cytotoxic reaction against melanoma tumor cells and provide surprisingly durable anticancer response with prolongation of the patients ‘survival.